News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioCryst Pharmaceuticals, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Bio NC
Top 5 Biotech Winners and Losers of Q1 2016
March 31, 2016
·
3 min read
FDA
FDA Approves Biocryst Pharmaceuticals’s Intravenous Flu Drug Rapivab
December 22, 2014
·
2 min read
BioCapital
Ebola Clinical Trials: Big Name Players In The Ebola Race
October 20, 2014
·
12 min read
Biotech Beach
The Day In Review: Novartis Pharmaceuticals Corporation Gets Approval For Hypertensive Drug Tekturna
March 6, 2007
·
1 min read
Biotech Beach
The Week In Review: Biotech Ends Q3 With A Bang
October 3, 2006
·
1 min read
Biotech Beach
The Day In Review: Amgen Buys Avidia, Inc. For $290 Million
October 3, 2006
·
1 min read
Biotech Bay
The Day In Review: Amgen Gets Approval For Vectibix
September 27, 2006
·
1 min read
Biotech Beach
The Day In Review: Immunicon Corporation Rises On AstraZeneca PLC Deal
August 7, 2006
·
1 min read
Biotech Beach
The Day In Review: Pfizer Inc. Buys Obesity Compound From Bayer Corporation
June 14, 2006
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 2, 2026
July 2, 2026
·
1 min read
Press Releases
BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility
June 29, 2026
·
9 min read
Press Releases
BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of HAE Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
June 12, 2026
·
11 min read
Press Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 9, 2026
June 10, 2026
·
1 min read
Press Releases
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
May 27, 2026
·
7 min read
Press Releases
BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026
May 13, 2026
·
4 min read
Press Releases
BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update
May 6, 2026
·
13 min read
Press Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 5, 2026
May 5, 2026
·
1 min read
Press Releases
BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema
May 4, 2026
·
6 min read
Press Releases
BioCryst to Present at Upcoming Investor Conferences - April 28, 2026
April 28, 2026
·
1 min read
